| Elesclomol |
ENSG00000005206.12 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000104691.10 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000130600.11 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000130600.11 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000131484.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000152931.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000163597.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000170161.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000175147.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000175772.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000175873.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000175967.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000176728.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000177410.8 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000177993.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000178947.8 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000179743.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000180712.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000180769.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000182873.4 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000183242.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000184068.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000184324.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000185186.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000185837.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000187904.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000188206.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000188660.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000188660.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000189238.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000196295.7 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000196810.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000197085.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000197813.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000198106.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000203395.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000203706.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000203849.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000203849.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000203865.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000203886.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000203999.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000204011.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000204362.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000204581.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000204588.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000204603.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000204625.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000204792.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000204815.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000204832.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000204837.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000204860.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000204949.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000205266.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000206028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000206129.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000206140.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000212163.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000212766.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000213971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000214145.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000214184.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000214353.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000214719.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000214733.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000214803.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000214870.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000214870.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000214870.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000214894.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000214922.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000215023.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000215039.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000215068.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000215068.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000215374.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000215417.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000215808.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000215859.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000218839.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000221571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000221817.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000223396.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000223401.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000223442.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000223466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000223477.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000223522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000223571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000223642.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000223678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000223714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000223714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000223745.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000223749.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000223764.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000223804.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000223813.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000223935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000223975.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000224032.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000224043.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000224043.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000224090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000224093.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000224157.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000224184.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000224271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000224276.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000224276.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000224349.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000224468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000224505.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000224596.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000224616.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000224635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000224655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000224699.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000224721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000224745.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000224799.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000224804.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000224844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000224844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000224846.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000224884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000224884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000224884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000224945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000224965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225113.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000225218.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000225265.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000225292.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000225311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225353.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225353.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000225434.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000225489.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000225490.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000225506.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225527.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000225535.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000225555.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000225675.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000225703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000225725.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000225783.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225913.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000225931.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000225945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000226007.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000226047.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000226089.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000226097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000226263.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000226287.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000226291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000226310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000226330.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000226440.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000226440.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226471.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000226471.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000226520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226562.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000226578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000226578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000226659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000226669.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226676.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000226711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226758.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000226833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000226835.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000226853.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000226864.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000226869.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000226889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000226900.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000226904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000226963.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000227017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227053.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000227161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000227172.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000227220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000227290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000227354.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000227359.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000227388.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227403.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000227438.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000227477.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000227495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000227496.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000227518.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000227533.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000227533.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000227589.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227719.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000227726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000227726.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000227744.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000227773.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000227953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000228037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000228172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000228223.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000228237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000228318.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000228322.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000228323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000228323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228422.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228452.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000228463.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000228478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000228486.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000228495.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000228509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000228527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228549.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228634.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000228634.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000228661.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000228679.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228686.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000228692.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000228705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000228719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000228784.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228809.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000228838.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000228852.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000228857.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000228862.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228933.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000228952.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000228962.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000228972.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000229017.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000229036.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000229105.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000229109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229127.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229278.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000229352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229463.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000229498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229536.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000229688.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000229739.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229807.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000229862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000229869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000229873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000229891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000229893.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000230002.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000230068.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000230212.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000230212.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000230310.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000230310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000230319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000230366.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000230415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000230417.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000230439.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000230461.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000230470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000230487.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000230513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000230523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000230530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000230530.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000230561.3 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000230606.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000230613.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000230663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000230699.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000230812.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000230817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000230836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000230881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000230912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000230943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000230970.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000231024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000231064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000231104.4 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000231113.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000231133.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000231154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000231187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231201.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000231212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000231212.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000231233.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000231249.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231312.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000231327.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000231335.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000231473.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000231481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000231519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000231527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231535.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000231551.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000231563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000231566.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000231651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231776.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231789.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000231992.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000231999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000232043.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232104.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000232118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000232139.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000232139.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000232151.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232229.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232233.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000232259.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000232284.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000232311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000232406.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000232412.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000232490.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000232611.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232684.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000232686.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000232725.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000232739.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000232811.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000232828.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000232874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232884.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000232884.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000232913.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000232934.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000232936.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000232969.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000233058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233064.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233064.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000233073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000233098.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233101.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000233153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233184.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000233203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233360.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000233421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233536.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000233547.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000233547.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000233611.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233621.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000233776.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000233806.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000233844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000233895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000233895.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000233953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000234084.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000234147.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000234155.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000234160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000234171.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000234185.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000234193.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000234208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234222.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000234225.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000234264.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000234286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234327.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000234327.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000234350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000234428.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000234460.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000234535.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000234608.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000234617.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000234665.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000234678.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000234690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234705.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000234707.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000234753.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000234818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000234828.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000234871.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000234880.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000234899.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000234913.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000234945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000234978.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000235027.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000235070.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000235079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000235096.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000235106.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000235117.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000235123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000235126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000235151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000235204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000235271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235298.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000235314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000235326.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000235358.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000235358.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000235408.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000235423.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000235445.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235501.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000235565.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000235609.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000235652.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000235703.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000235726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000235831.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000235843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000235899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236095.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000236115.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000236137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236200.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000236204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236256.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000236256.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000236266.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000236276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000236308.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000236337.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000236352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236383.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000236383.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000236393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236394.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000236581.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236682.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236778.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000236780.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236908.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000236935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000236943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000237036.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237187.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000237200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000237298.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000237331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000237338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000237357.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000237361.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000237399.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000237407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000237438.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000237461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000237491.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000237499.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000237531.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000237588.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237686.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000237689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000237697.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000237697.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000237737.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000237772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000237773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000237773.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000237786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000237852.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000237852.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000237857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237877.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000237921.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000237927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000237934.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000237940.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000238043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000238068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000238120.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000238133.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000238140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000238164.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000238178.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000238186.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000238210.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000239353.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000239523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000239636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000239677.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000239705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000240015.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000240063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000240254.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000240288.3 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000240350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000240423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000240423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000240766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000241014.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000241135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000241135.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000241180.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000241211.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000241288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000241316.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000241472.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000241481.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000241481.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000241818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000241990.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000242391.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000242641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000242861.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000242925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000243230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000243243.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000243479.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000243533.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000244300.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000244306.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000244345.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000244383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000244558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000244586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000244733.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000245059.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000245080.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000245281.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000245532.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000245685.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000246174.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000246250.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000246308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000246363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000246876.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000246898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000246898.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000247081.3 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000247095.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000247131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000247151.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000247311.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000247324.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000247373.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000247373.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000247516.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000247556.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000247624.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000247765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000247775.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000247950.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000248103.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000248265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000248275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000248309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000248309.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000248516.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000248533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000248559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000248571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000248664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000248668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000248690.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000248734.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000248740.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000248787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000248810.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000248890.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000248925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000248936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000249035.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000249084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000249096.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000249249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000249249.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000249307.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000249328.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000249359.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000249359.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000249412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000249476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000249593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000249595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000249664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000249700.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000249700.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000249717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000249738.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000249746.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000249791.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000249791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000249806.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000249868.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000249885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000249899.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250039.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250039.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000250049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000250156.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000250271.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000250280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000250312.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000250312.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000250397.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000250410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000250522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000250546.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000250596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000250608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000250608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000250764.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250790.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000250822.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000250842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000250842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000250889.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000250889.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250893.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000250899.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000250903.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000250990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000251018.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000251034.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000251059.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000251072.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000251136.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000251169.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000251205.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000251257.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000251307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000251365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000251365.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000251417.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000251432.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000251513.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000251556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000251603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000251603.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000251611.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000251665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000253121.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000253172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000253263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000253298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000253392.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000253394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000253395.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000253408.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000253438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000253539.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000253557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000253562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000253586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000253608.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000253636.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000253660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000253695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000253730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000253837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000253854.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000253930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254003.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000254027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000254099.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000254144.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000254162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000254165.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000254207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000254263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000254275.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000254302.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000254315.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254340.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000254353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000254414.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000254431.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000254459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000254539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254539.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000254551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254631.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000254671.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000254682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000254744.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000254814.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000254821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000254859.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000254864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000254880.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000254934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000254966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000255031.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000255031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000255031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000255052.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000255080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000255120.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000255237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000255248.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000255343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000255348.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000255455.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000255496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000255568.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000255580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000255595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000255717.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000255741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000256050.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000256084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000256150.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000256196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000256226.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000256377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000256458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000256538.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000256576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000256588.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000256603.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000256811.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000257038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000257038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000257084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000257252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000257256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000257322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000257329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000257381.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000257449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000257449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000257530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000257556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000257563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000257588.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000257671.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000257718.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000257769.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000257900.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000257900.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000257964.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000258048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000258096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000258136.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000258172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000258188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000258303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000258443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000258486.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000258525.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000258526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000258654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000258730.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000258731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000258735.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000258811.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000258813.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000258843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000258858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000258920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000258922.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000258929.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000258940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259005.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000259048.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000259062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000259065.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000259081.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000259087.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259135.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000259204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259212.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259306.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000259351.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259380.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000259396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000259402.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259416.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000259469.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000259475.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259523.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259551.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000259604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259617.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259617.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000259631.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259654.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000259659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259673.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259694.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000259701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259717.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000259717.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000259755.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000259797.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000259806.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000259807.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000259810.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000259820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259840.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000259840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259876.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000259884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259915.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000259929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000259959.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000259994.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000260022.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260025.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000260070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260100.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000260118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260145.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000260167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260209.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000260213.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000260265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000260281.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000260288.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260392.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000260417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260418.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000260430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000260464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000260479.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260517.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000260545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260552.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000260563.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000260572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260616.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260625.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000260626.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000260693.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000260698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000260766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000260790.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000260841.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000260871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000260905.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000260911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000260938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000260948.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000260949.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000260977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000260996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000261000.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000261015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261019.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000261036.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000261043.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000261087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000261183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000261183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000261186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000261195.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261204.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000261241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000261296.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000261305.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000261305.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000261326.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261360.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000261369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000261441.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000261455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000261471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000261490.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000261504.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000261534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261534.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000261572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261578.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000261582.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000261592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261630.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000261634.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000261654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000261664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261690.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000261690.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000261693.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000261716.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000261728.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261737.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000261786.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000261790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261823.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000261838.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000261839.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000261840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000261864.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000262074.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000262098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000262152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000262265.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000262296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262339.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000262410.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000262454.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000262454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000262468.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000262514.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000262580.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000262652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262663.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000262686.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000262721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000262772.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000262810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000262823.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000262848.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000262873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262879.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000262920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000262979.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000263063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000263220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000263257.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000263316.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000263345.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000263400.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000263470.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000263531.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000263603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000263644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000263680.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000263683.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000263727.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000263753.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000263786.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000263843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000263847.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000263893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000263975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000263975.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000263982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000264015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000264026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000264078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000264078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000264112.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000264125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000264304.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000264448.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000264469.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000264546.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000264575.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000264672.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000264673.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000264808.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000264914.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000264920.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000264940.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000264954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000264968.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000265055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000265218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000265334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000265413.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000265487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000265666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000265692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000265739.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000265778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000265800.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000266236.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000266236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000266289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266290.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000266311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266340.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000266411.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000266469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000266498.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000266644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266651.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000266654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000266677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000266783.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000266783.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000266821.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000266877.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000266913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266916.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000266918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000266934.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000266934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000266942.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000266950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000266957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000266969.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000266994.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000267006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000267011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000267011.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000267016.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000267025.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000267040.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000267057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000267082.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000267100.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000267108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000267118.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000267121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267141.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000267147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267222.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000267230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000267272.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000267275.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000267277.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000267325.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000267327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267327.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000267375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000267375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000267383.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000267397.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000267405.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000267417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000267421.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267449.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000267476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267501.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000267501.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000267505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267530.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267539.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000267547.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000267549.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267667.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000267677.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000267712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267715.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000267729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000267730.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000267745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000267787.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000267808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000267919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000267992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000268006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000268049.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000268061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000268066.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000268095.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000268157.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000268231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000268316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000268340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000268543.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000268544.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000268573.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000268621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000268756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000268912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000269107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000269191.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000269202.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000269293.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000269473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000269486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269524.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000269680.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000269688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269867.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000269873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269887.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000269893.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000269900.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000269902.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000269923.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000269925.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000269938.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000269942.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000269947.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000269956.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000269956.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000269961.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000269999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000270001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000270040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000270041.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000270062.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000270062.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270069.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000270076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000270077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270103.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000270108.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000270112.2 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000270127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000270133.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000270157.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000270174.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000270190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000270195.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000270210.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000270346.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000270462.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000270562.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000270571.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000270580.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000270607.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000270641.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270742.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000270761.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000270761.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000270933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271020.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000271032.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000271119.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000271151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271151.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000271218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000271234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271259.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271314.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271324.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000271327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271522.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271659.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000271734.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000271742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000271781.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000271811.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000271826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000271826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271851.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000271856.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000271912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000271964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000271967.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000271973.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000271975.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000271978.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000271981.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000271996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000272009.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000272023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272072.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000272091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000272093.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000272097.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000272112.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000272138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000272141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272141.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000272143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000272144.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272221.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000272236.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000272264.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272275.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000272365.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000272370.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272420.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000272462.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000272473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272518.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000272556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272567.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000272604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272630.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272639.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272657.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000272657.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272668.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000272695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000272825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272859.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000272862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000272902.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272902.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000272913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000272953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000272977.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000272983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000272989.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000272992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000272993.1 |
Predicted lncRNA |
Sarcoma |
|
| Elesclomol |
ENSG00000272995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273001.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000273012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273014.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000273058.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000273065.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000273069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273076.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000273081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000273113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273148.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000273153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000273175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000273175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000273176.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000273237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Elesclomol |
ENSG00000273265.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Elesclomol |
ENSG00000273270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000273297.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000273305.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Elesclomol |
ENSG00000273311.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000273319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Elesclomol |
ENSG00000273343.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Elesclomol |
ENSG00000273344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273352.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Elesclomol |
ENSG00000273355.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Elesclomol |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273443.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Elesclomol |
ENSG00000273447.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Elesclomol |
ENSG00000273481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000273481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Elesclomol |
ENSG00000273487.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Elesclomol |
ENSG00000273493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|